In the evolving landscape of medical cannabis, few names resonate as strongly as Constance Finley, the visionary force behind Constance CBD. With nearly two decades of dedication, Finley has been at the forefront of developing high-quality, science-driven cannabis products aimed at treating serious medical conditions. This article delves into the pioneering work of Constance CBD, highlighting their commitment to medicinal applications over recreational use, scientific rigor, and personalized patient care.
Pioneering the Science of Medicinal Cannabis
Constance CBD has been a trailblazer in the medical cannabis industry, setting a precedent by being the first to sell CBD commercially worldwide. Constance Finley’s passion for science has driven her to explore how both CBD and THC can be more beneficial for individuals with limited treatment options. Unlike many in the industry, Constance CBD’s focus has always been on medicinal applications, steering clear of recreational cannabis.
Innovative Extraction Methods and Genetic Consistency
One of the standout features of Constance Therapeutics is their unique approach to cannabis extraction and genetic consistency. “We have worked with the same large group of genetics in cannabinoid plants for over 18 years,” Finley explains. This extensive research has allowed them to understand the terpenes and genetic profiles of their strains, ensuring precision in their formulations for various needs.
Finley’s invention of a unique ethanol-based extraction method marked a significant advancement in the industry. “Our company was the first to use ethanol in cannabis extraction,” she notes, emphasizing the meticulous care taken to ensure the safety and efficacy of their products. This method preserves the essence of the genetics, making their extraction methodology a labor-intensive yet superior approach.
Standardization and Personalized Care
Standardization in cannabis products is rare, yet Constance CBD has achieved pharmaceutical-level consistency through proprietary software developed in collaboration with UC Berkeley and statisticians in South Africa. This ensures that every product meets rigorous standards, providing patients with reliable and effective treatments.
Personalized patient care is a cornerstone of Constance CBD’s philosophy. With over 2,700 patients in their database, many of whom were or are terminally ill, the company offers individualized treatment plans and coaching. “Full spectrum plant medicine tends to be more personalized,” Finley asserts, highlighting the importance of tailoring treatments to each patient’s unique needs.
The Role of Cannabis in Treating Serious Conditions
Cannabis offers a wealth of potential for patients with limited options, particularly those suffering from cancer, Lyme disease, epilepsy, and chronic pain. Constance CBD has conducted open-label studies on these conditions, holding multiple patents on their formulations and extraction methods. “We have a cure for cancer pending in our patents in the EU and a cure for Lyme in our patents in the U.S.,” Finley reveals, underscoring the groundbreaking nature of their work.
Advocating for Plant Medicine
Constance Finley is a staunch advocate for plant-based medicine, challenging the pharmaceutical industry’s reliance on isolated compounds. She believes that cannabis is opening up a broader conversation about returning to plant-based treatments. “It’s not enough to say it is a plant or “natural”; it goes so much deeper than that,” she emphasizes.
Final Thoughts
Constance Finley and Constance CBD are redefining the medical cannabis landscape with their innovative approaches and unwavering commitment to patient-centered care. As the world increasingly recognizes the potential of plant medicine, Constance CBD stands as a beacon of scientific rigor and compassionate care. To learn more about their pioneering work, visit Constance Therapeutics and explore how they are shaping the future of medical cannabis.
